Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy

Stem Cells and Development

Volumn 25, Issue 24, 2016, Pages 1863-1873

  Smith, Drake J ^a   Lin, Levina J ^a   Moon, Heesung ^a   Pham, Alexander T ^a   Wang, Xi ^a   Liu, Siyuan ^a   Ji, Sunjong ^a   Rezek, Valerie ^a,b   Shimizu, Saki ^a   Ruiz, Marlene ^a   Lam, Jennifer ^a   Janzen, Deanna M ^a   Memarzadeh, Sanaz ^a,b   Kohn, Donald B ^a,b   Zack, Jerome A ^a,b   Kitchen, Scott G ^a,b   An, Dong Sung ^a   Yang, Lili ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD34; HSC; human immunology; human immunotherapy; humanized BLT mice; propagating

Indexed keywords

CD34 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; HLA A2 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FETUS; GENETIC TRAIT; HAPLOTYPE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOLOGY; IMMUNOTHERAPY; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; T LYMPHOCYTE; THYMUS; THYMUS GRAFT; ANIMAL; CELL LINEAGE; CYTOLOGY; GENETICS; INHERITANCE; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; SCID MOUSE;

ALLERGY AND IMMUNOLOGY; ANIMALS; BONE MARROW; CELL LINEAGE; HUMANS; IMMUNOTHERAPY; INHERITANCE PATTERNS; LIVER; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES; THYMUS GLAND;

EID: 85004073500     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2016.0193     Document Type: Article

References (40)

1. Shultz LD, MA Brehm, JV Garcia-Martinez and DL Greiner. (2012). Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12:786-798.
2. Rongvaux A, H Takizawa, T Strowig, T Willinger, EE Eynon, RA Flavell and MG Manz. (2013). Human hematolymphoid system mice: current use and future potential for medicine. Annu Rev Immunol 31:635-674.
3. Theocharides AP, A Rongvaux, K Fritsch, RA Flavell and MG Manz. (2016). Humanized hemato-lymphoid system mice. Haematologica 101:5-19.
4. Brehm MA, A Cuthbert, C Yang, DM Miller, P DiIorio, J Laning, L Burzenski, B Gott, O Foreman, et al. (2010). Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation. Clin Immunol 135:84-98.
5. Takenaka K, TK Prasolava, JC Wang, SM Mortin-Toth, S Khalouei, OI Gan, JE Dick and JS Danska. (2007). Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 8:1313-1323.
6. Mosier DE, RJ Gulizia, SM Baird and DB Wilson. (1988). Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-259.
7. Traggiai E, L Chicha, L Mazzucchelli, L Bronz, JC Piffaretti, A Lanzavecchia and MG Manz. (2004). Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104-107.
8. Chicha L, R Tussiwand, E Traggiai, L Mazzucchelli, L Bronz, JC Piffaretti, A Lanzavecchia and MG Manz. (2005). Human adaptive immune system Rag2-/-gamma(c)-/-mice. Ann N Y Acad Sci 1044:236-243.
9. McCune JM, R Namikawa, H Kaneshima, LD Shultz, M Lieberman and IL Weissman. (1988). The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1639.
10. Melkus MW, JD Estes, A Padgett-Thomas, J Gatlin, PW Denton, FA Othieno, AK Wege, AT Haase and JV Garcia. (2006). Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12:1316-1322.
11. Lan P, N Tonomura, A Shimizu, S Wang and YG Yang. (2006). Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 108:487-492.
12. Wege AK, MW Melkus, PW Denton, JD Estes and JV Garcia. (2008). Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 324:149-165.
13. Brainard DM, E Seung, N Frahm, A Cariappa, CC Bailey, WK Hart, HS Shin, SF Brooks, HL Knight, et al. (2009). Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 83:7305-7321.
14. Marsden MD and JA Zack. (2015). Studies of retroviral infection in humanized mice. Virology 479-480:297-309.
15. Karpel ME, CL Boutwell and TM Allen. (2015). BLT humanized mice as a small animal model of HIV infection. Curr Opin Virol 13:75-80.
16. Garcia JV. (2016). In vivo platforms for analysis of HIV persistence and eradication. J Clin Invest 126:424-431.
17. Tager AM, M Pensiero and TM Allen. (2013). Recent advances in humanized mice: accelerating the development of an HIV vaccine. J Infect Dis 208 Suppl 2:S121-S124.
18. Shimizu S, P Hong, B Arumugam, L Pokomo, J Boyer, N Koizumi, P Kittipongdaja, A Chen, G Bristol, et al. (2010). A highly efficient short hairpin RNA potently downregulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood 115:1534-1544.
19. Vatakis DN, RC Koya, CC Nixon, L Wei, SG Kim, P Avancena, G Bristol, D Baltimore, DB Kohn, et al. (2011). Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proc Natl Acad Sci USA 108:E1408-E1416.
20. Carbonaro DA, L Zhang, X Jin, C Montiel-Equihua, S Geiger, M Carmo, A Cooper, L Fairbanks, ML Kaufman, et al. (2014). Preclinical demonstration of lentiviral vectormediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Mol Ther 22:607-622.
21. Hoban MD, GJ Cost, MC Mendel, Z Romero, ML Kaufman, AV Joglekar, M Ho, D Lumaquin, D Gray, et al. (2015). Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells. Blood 125:2597-2604.
22. Romero Z, F Urbinati, S Geiger, AR Cooper, J Wherley, ML Kaufman, RP Hollis, RR de Assin, S Senadheera, et al. (2013). Beta-globin gene transfer to human bone marrow for sickle cell disease. J Clin Invest 123:3317-3330.
23. Smith DJ, S Liu, S Ji, B Li, J McLaughlin, D Cheng, ON Witte and L Yang. (2015). Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells. Proc Natl Acad Sci USA 112:1523-1528.
24. Giannoni F, CL Hardee, J Wherley, E Gschweng, S Senadheera, ML Kaufman, R Chan, I Bahner, V Gersuk, et al. (2013). Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells. Mol Ther 21:1044-1054.
25. Yang L, H Yang, K Rideout, T Cho, KI Joo, L Ziegler, A Elliot, A Walls, D Yu, D Baltimore and P Wang. (2008). Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol 26:326-334.
26. Watanabe N, YH Wang, HK Lee, T Ito, YH Wang, W Cao and YJ Liu. (2005). Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 436:1181-1185.
27. Spits H. (2002). Development of alphabeta T cells in the human thymus. Nat Rev Immunol 2:760-772.
28. Choo SY. (2007). The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J 48:11-23.
29. Tscharke DC, NP Croft, PC Doherty and NL La Gruta. (2015). Sizing up the key determinants of the CD8(+) T cell response. Nat Rev Immunol 15:705-716.
30. Rossi JJ, CH June and DB Kohn. (2007). Genetic therapies against HIV. Nat Biotechnol 25:1444-1454.
31. Gschweng E, S De Oliveira and DB Kohn. (2014). Hematopoietic stem cells for cancer immunotherapy. Immunol Rev 257:237-249.
32. Kuo CY and DB Kohn. (2016). Gene Therapy for the Treatment of Primary Immune Deficiencies. Curr Allergy Asthma Rep 16:39.
33. Wang CX and PM Cannon. (2016). The clinical applications of genome editing in HIV. Blood 127:2546-2552.
34. Petz LD, JC Burnett, H Li, S Li, R Tonai, M Bakalinskaya, EJ Shpall, S Armitage, J Kurtzberg, et al. (2015). Progress toward curing HIV infection with hematopoietic cell transplantation. Stem Cells Cloning 8:109-116.
35. Kershaw MH, JA Westwood and PK Darcy. (2013). Geneengineered T cells for cancer therapy. Nat Rev Cancer 13: 525-541.
36. Zaunders J and D van Bockel. (2013). Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease. Front Immunol 4:95.
37. Cosgun KN, S Rahmig, N Mende, S Reinke, I Hauber, C Schafer, A Petzold, H Weisbach, G Heidkamp, et al. (2014). Kit regulates HSC engraftment across the humanmouse species barrier. Cell Stem Cell 15:227-238.
38. McIntosh BE, ME Brown, BM Duffin, JP Maufort, DT Vereide, Slukvin, II and JA Thomson. (2015). Nonirradiated NOD,B6.SCID Il2rgamma-/-Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells. Stem Cell Rep 4:171-180.
39. Strowig T, A Rongvaux, C Rathinam, H Takizawa, C Borsotti, W Philbrick, EE Eynon, MG Manz and RA Flavell. (2011). Transgenic expression of human signal regulatory protein alpha in Rag2-/-gamma(c)-/-mice improves engraftment of human hematopoietic cells in humanized mice. Proc Natl Acad Sci USA 108:13218-13223.
40. Rongvaux A, T Willinger, J Martinek, T Strowig, SV Gearty, LL Teichmann, Y Saito, F Marches, S Halene, et al. (2014). Development and function of human innate immune cells in a humanized mouse model. Nat Biotechnol 32:364-372.